GPS Wealth Strategies Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353K | Sell |
5,108
-432
| -8% | -$29.8K | 0.04% | 228 |
|
|
2025
Q1 | $385K | Sell |
5,540
-298
| -5% | -$20.7K | 0.05% | 212 |
|
|
2024
Q4 | $502K | Sell |
5,838
-947
| -14% | -$81.5K | 0.06% | 169 |
|
|
2024
Q3 | $808K | Buy |
6,785
+1,013
| +18% | +$121K | 0.11% | 132 |
|
|
2024
Q2 | $824K | Buy |
5,772
+847
| +17% | +$121K | 0.12% | 116 |
|
|
2024
Q1 | $632K | Buy |
4,925
+1,578
| +47% | +$203K | 0.1% | 135 |
|
|
2023
Q4 | $346K | Buy |
3,347
+1,215
| +57% | +$126K | 0.06% | 186 |
|
|
2023
Q3 | $194K | Buy |
2,132
+82
| +4% | +$7.46K | 0.04% | 250 |
|
|
2023
Q2 | $166K | Buy |
2,050
+1,564
| +322% | +$127K | 0.03% | 264 |
|
|
2023
Q1 | $38.6K | Buy |
+486
| New | +$38.6K | 0.01% | 531 |
|
|
2022
Q4 | – | Sell |
-660
| Closed | -$33K | – | 762 |
|
|
2022
Q3 | $33K | Buy |
660
+4
| +0.6% | +$200 | 0.01% | 512 |
|
|
2022
Q2 | $37K | Buy |
656
+4
| +0.6% | +$226 | 0.01% | 501 |
|
|
2022
Q1 | $36K | Hold |
652
| – | – | 0.01% | 478 |
|
|
2021
Q4 | $37K | Hold |
652
| – | – | 0.01% | 468 |
|
|
2021
Q3 | $31K | Buy |
652
+2
| +0.3% | +$95 | 0.01% | 490 |
|
|
2021
Q2 | $27K | Buy |
650
+6
| +0.9% | +$249 | 0.01% | 532 |
|
|
2021
Q1 | $21K | Buy |
+644
| New | +$21K | 0.01% | 536 |
|